This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2006 Nov;24(5):565-78.

doi: 10.1007/s00345-006-0119-6.

Molecular markers of prognosis and novel therapeutic strategies for urothelial cell carcinomas

Christopher Y Thomas¹, Dan Theodorescu

Affiliations

PMID: 17063322
DOI: 10.1007/s00345-006-0119-6

Review

Molecular markers of prognosis and novel therapeutic strategies for urothelial cell carcinomas

Christopher Y Thomas et al. World J Urol. 2006 Nov.

. 2006 Nov;24(5):565-78.

doi: 10.1007/s00345-006-0119-6.

Authors

Christopher Y Thomas¹, Dan Theodorescu

Affiliation

¹ Department of Hematology and Oncology, UVA HSC, P.O. Box 800716, Charlottesville, VA 22908, USA.

PMID: 17063322
DOI: 10.1007/s00345-006-0119-6

No abstract available

PubMed Disclaimer

Similar articles

Global gene expression profiling identifies ALDH2, CCNE1 and SMAD3 as potential prognostic markers in upper tract urothelial carcinoma.
Wu S, Chen J, Dong P, Zhang S, He Y, Sun L, Zhu J, Cheng Y, Li X, Tang A, Huang Y, Gui Y, Liu C, Yang G, Zhou F, Cai Z, Wang R. Wu S, et al. BMC Cancer. 2014 Nov 18;14:836. doi: 10.1186/1471-2407-14-836. BMC Cancer. 2014. PMID: 25408144 Free PMC article.
GPX2 underexpression indicates poor prognosis in patients with urothelial carcinomas of the upper urinary tract and urinary bladder.
Chang IW, Lin VC, Hung CH, Wang HP, Lin YY, Wu WJ, Huang CN, Li CC, Li WM, Wu JY, Li CF. Chang IW, et al. World J Urol. 2015 Nov;33(11):1777-89. doi: 10.1007/s00345-015-1522-7. Epub 2015 Mar 27. World J Urol. 2015. PMID: 25813210
Tissue microarrays: applications in urological cancer research.
Merseburger AS, Anastasiadis AG, Hennenlotter J, Schilling D, Simon P, Machtens SA, Serth J, Stenzl A, Kuczyk MA. Merseburger AS, et al. World J Urol. 2006 Nov;24(5):579-84. doi: 10.1007/s00345-006-0103-1. Epub 2006 Aug 9. World J Urol. 2006. PMID: 16896596 Review.
DPP4/CD26 overexpression in urothelial carcinoma confers an independent prognostic impact and correlates with intrinsic biological aggressiveness.
Liang PI, Yeh BW, Li WM, Chan TC, Chang IW, Huang CN, Li CC, Ke HL, Yeh HC, Wu WJ, Li CF. Liang PI, et al. Oncotarget. 2017 Jan 10;8(2):2995-3008. doi: 10.18632/oncotarget.13820. Oncotarget. 2017. PMID: 27936466 Free PMC article.
Molecular aspects of upper tract urothelial carcinoma.
Patel N, Arya M, Muneer A, Powles T, Sullivan M, Hines J, Kelly J. Patel N, et al. Urol Oncol. 2014 Jan;32(1):28.e11-20. doi: 10.1016/j.urolonc.2012.10.002. Epub 2013 Feb 19. Urol Oncol. 2014. PMID: 23428541 Review.

See all similar articles

Cited by

Molecular markers in transitional cell carcinoma of the bladder: New insights into mechanisms and prognosis.
Ehdaie B, Theodorescu D. Ehdaie B, et al. Indian J Urol. 2008 Jan;24(1):61-7. doi: 10.4103/0970-1591.38606. Indian J Urol. 2008. PMID: 19468362 Free PMC article.
RGS6 is an essential tumor suppressor that prevents bladder carcinogenesis by promoting p53 activation and DNMT1 downregulation.
Yang J, Platt LT, Maity B, Ahlers KE, Luo Z, Lin Z, Chakravarti B, Ibeawuchi SR, Askeland RW, Bondaruk J, Czerniak BA, Fisher RA. Yang J, et al. Oncotarget. 2016 Oct 25;7(43):69159-69172. doi: 10.18632/oncotarget.12473. Oncotarget. 2016. PMID: 27713144 Free PMC article.
Alterations of dendritic cell subsets and TH1/TH2 cytokines in the peripheral circulation of patients with superficial transitional cell carcinoma of the bladder.
Lang F, Linlin M, Ye T, Yuhai Z. Lang F, et al. J Clin Lab Anal. 2012 Sep;26(5):365-71. doi: 10.1002/jcla.21532. J Clin Lab Anal. 2012. PMID: 23001982 Free PMC article.
New and promising strategies in the management of bladder cancer.
Apolo AB, Vogelzang NJ, Theodorescu D. Apolo AB, et al. Am Soc Clin Oncol Educ Book. 2015:105-12. doi: 10.14694/EdBook_AM.2015.35.105. Am Soc Clin Oncol Educ Book. 2015. PMID: 25993148 Free PMC article. Review.
Immunoscreening of urinary bladder cancer cDNA library and identification of potential tumor antigen.
Chen L, Chen W, Zhao L, Yu HZ, Li X. Chen L, et al. World J Urol. 2009 Feb;27(1):107-12. doi: 10.1007/s00345-008-0326-4. Epub 2008 Oct 1. World J Urol. 2009. PMID: 18828023

References

1. Cancer Res. 2005 Oct 15;65(20):9109-12 - PubMed
1. J Clin Oncol. 2005 Aug 10;23 (23 ):5294-304 - PubMed
1. Clin Cancer Res. 2003 Sep 1;9(10 Pt 1):3578-88 - PubMed
1. Am J Pathol. 2001 Jun;158(6):1955-9 - PubMed
1. Urology. 2005 Dec;66(6 Suppl 1):64-74 - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Springer